Ixabepilone and the narrow path to developing new cytotoxic drugs.
Gianni
Luca
L
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D002986:Clinical Trials as Topic; D015195:Drug Design; D034261:Epothilones / Q000737:chemistry / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D014404:Tubulin / Q000737:chemistry
D000970:Antineoplastic Agents; D034261:Epothilones; D014404:Tubulin; C430592:ixabepilone; C093788:epothilone B